in

Biotechnology company: Macrocure Ltd. (MCUR) (2008)

Macrocure Ltd. (NASDAQ: MCUR) was founded in 2008 and is headquartered in Petah Tikva, Israel. It has 28 full-time employees. It is a regenerative medicine company that focuses on the development, production and commercialization of chronic and other treatments in Israel New cell therapy products for difficult-to-heal wounds.

Macrocure Ltd MCUR Logo

Macrocure Ltd. (MCUR):

Macrocure is a biotechnology company, mainly engaged in the development, manufacturing, and commercialization of cell therapy products, which are used to treat less-healing or chronic wounds, and other regenerative medicine applications. The company’s core cell biological products include CureXcell, which has entered two key phase III clinical trials (approved for marketing in Israel) for the treatment of non-healing foot ulcers and lower limb venous ulcers caused by diabetes.

Macrocure is expected to produce test results in the second half of 2015. If it goes well, it will submit a new drug application in 2016. In addition to the United States, the company is also actively exploring the European market.

Macrocure Ltd. (MCUR) investment:

August 20, 2015: The test results of the main product candidate CureXcell fell short of expectations, and Macrocure’s stock plummeted -75.27%.

Macrocure (MCUR) recent rating record

Rating date

Rating company

Up/down

Initial rating

Latest rating

2015-8-21

Credit Suisse

Downgrade

Overweight

neutral

2015-8-20

Nomura

Downgrade

Buy in

neutral

2015-8-20

Oppenheimer

Downgrade

Outperform the market

Consistent with the big market

2015-8-20

Jefferies

Downgrade

Buy in

hold

Company official website: http://www.macrocure.com/

Market trend: http://xueqiu.com/S/MCUR

American Stock Encyclopedia: https://www.thisyear.com/mcur.html

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

The world’s largest water treatment equipment manufacturer: Pentair plc (PNR) (1966)

Business security and fire control leader: Tyco International (TYC)-delisting (1960)